Browsing: covaxin trials

The US Food and Drug Administration which has put on hold the phase 2/ 3 clinical trials of Bharat Biotech’s…

The interim evaluation was based on 87 symptomatic circumstances of Covid-19.The interim outcomes of the Phase-3 trials for Covaxin have…

Vaccine manufacturer Bharat Biotech has lately reported the interim efficacy of its COVID-19 vaccine Covaxin at 81 per cent based…